Finance

Beta
Lists
HBIO:NASDAQ
Harvard Bioscience Inc
$5.87
-1.35%
(-0.081) 1D
May 29, 10:55:09 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HBIO...
Open
$5.97
High
$5.97
Low
$5.82
Mkt. cap
26.34M
Avg. vol.
36.87K
Volume
2.91K
52-wk high
$9.46
52-wk low
$3.10
EPS
-$2.20
Beta
1.57
Shares outstanding
4.51M
No. of employees
328
Open
$5.97
High
$5.97
Low
$5.82
Mkt. cap
26.34M
Avg. vol.
36.87K
Volume
2.91K
52-wk high
$9.46
52-wk low
$3.10
EPS
-$2.20
Beta
1.57
Shares outstanding
4.51M
No. of employees
328
News stories
From sources across the web
Profile
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany. Wikipedia
About Harvard Bioscience Inc
CEO-
Employees328
Founded1901
HeadquartersHolliston, Massachusetts, United States
SectorHealth care
Websiteharvardbioscience.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.45M
20.59M
23.74M
20.76M
Cost of goods sold
8.92M
8.57M
9.56M
8.51M
Cost of revenue
8.92M
8.57M
9.56M
8.51M
Research and development expenses
2.19M
2.13M
2.18M
2.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.80M
8.79M
7.81M
10.04M
Operating expense
12.15M
11.78M
10.85M
13.18M
Total operating expenses
21.07M
20.35M
20.41M
21.69M
Operating income
-619.00K
245.00K
3.32M
-939.00K
Other non operating income
-644.00K
-365.00K
-3.95M
-405.00K
EBT including unusual items
-2.25M
-1.13M
-3.20M
-3.31M
EBT excluding unusual items
-2.05M
-1.09M
-2.99M
-3.07M
Income tax expense
28.00K
97.00K
-357.00K
117.00K
Effective tax rate
-1.24%
-8.55%
11.14%
-3.54%
Other operating expenses
-
-
-
-
Net income
-2.28M
-1.23M
-2.85M
-3.42M
Net profit margin
-11.16%
-5.98%
-11.99%
-16.50%
Earnings per share
-0.10
-
-
-0.33
Interest and investment income
-
-
-
-
Interest expense
-791.00K
-966.00K
-2.36M
-1.73M
Net interest expenses
-791.00K
-966.00K
-2.36M
-1.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
997.00K
1.57M
4.68M
411.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer